These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 12549788

  • 1. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
    Tapaneya-Olarn W, Khositseth S, Tapaneya-Olarn C, Teerakarnjana N, Chaichanajarernkul U, Stitchantrakul W, Petchthong T.
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
    [Abstract] [Full Text] [Related]

  • 2. Dosage of potassium citrate in the correction of urinary abnormalities in pediatric distal renal tubular acidosis patients.
    Domrongkitchaiporn S, Khositseth S, Stitchantrakul W, Tapaneya-olarn W, Radinahamed P.
    Am J Kidney Dis; 2002 Feb; 39(2):383-91. PubMed ID: 11840381
    [Abstract] [Full Text] [Related]

  • 3. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients.
    Jaipakdee S, Prasongwatana V, Premgamone A, Reungjui S, Tosukhowong P, Tungsanga K, Suwantrai S, Noppawinyoowong C, Maskasame S, Sriboonlue P.
    J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041
    [Abstract] [Full Text] [Related]

  • 4. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 5. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S.
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [Abstract] [Full Text] [Related]

  • 6. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y, Hernandez N, Shoag J, Goldfarb DS, Eisner BH.
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [Abstract] [Full Text] [Related]

  • 7. Bone histology and bone mineral density after correction of acidosis in distal renal tubular acidosis.
    Domrongkitchaiporn S, Pongskul C, Sirikulchayanonta V, Stitchantrakul W, Leeprasert V, Ongphiphadhanakul B, Radinahamed P, Rajatanavin R.
    Kidney Int; 2002 Dec; 62(6):2160-6. PubMed ID: 12427141
    [Abstract] [Full Text] [Related]

  • 8. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY, Sakhaee K, Fuller CJ.
    Trans Assoc Am Physicians; 1983 Dec; 96():294-305. PubMed ID: 6679957
    [Abstract] [Full Text] [Related]

  • 9. [Renal tubular function in children with hypercalciuria].
    Kovacević L, Kovacević S, Smoljanić Z, Kostić M, Peco-Antić A, Gajić M, Kovacević M, Jovanović O.
    Srp Arh Celok Lek; 1998 Dec; 126(7-8):223-7. PubMed ID: 9863386
    [Abstract] [Full Text] [Related]

  • 10. Persistent and transient distal renal tubular acidosis with bicarbonate wasting.
    Leumann EP, Steinmann B.
    Pediatr Res; 1975 Oct; 9(10):767-73. PubMed ID: 241961
    [Abstract] [Full Text] [Related]

  • 11. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL.
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [Abstract] [Full Text] [Related]

  • 12. [Infantile transitory distal renal tubular acidosis with bicarbonate loss].
    Schabel F, Irnberger E.
    Padiatr Padol; 1985 Mar; 20(4):353-62. PubMed ID: 2867514
    [Abstract] [Full Text] [Related]

  • 13. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K, Poindexter JR, Griffith CS, Pak CY.
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome in children with primary distal renal tubular acidosis.
    Bajpai A, Bagga A, Hari P, Bardia A, Mantan M.
    Indian Pediatr; 2005 Apr; 42(4):321-8. PubMed ID: 15876593
    [Abstract] [Full Text] [Related]

  • 15. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY, Heller HJ, Pearle MS, Odvina CV, Poindexter JR, Peterson RD.
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [Abstract] [Full Text] [Related]

  • 16. Effect of potassium citrate therapy on the risk of renal stone formation during spaceflight.
    Whitson PA, Pietrzyk RA, Jones JA, Nelman-Gonzalez M, Hudson EK, Sams CF.
    J Urol; 2009 Nov; 182(5):2490-6. PubMed ID: 19765769
    [Abstract] [Full Text] [Related]

  • 17. Alkali absorption and citrate excretion in calcium nephrolithiasis.
    Sakhaee K, Williams RH, Oh MS, Padalino P, Adams-Huet B, Whitson P, Pak CY.
    J Bone Miner Res; 1993 Jul; 8(7):789-94. PubMed ID: 8352061
    [Abstract] [Full Text] [Related]

  • 18. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K, Erturhan S, Yurtseven C, Yagci F.
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [Abstract] [Full Text] [Related]

  • 19. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR, Leitao VA, Haleblian GE, Scales CD, Chandrashekar A, Pierre SA, Preminger GM.
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [Abstract] [Full Text] [Related]

  • 20. [Renal acidification mechanism disorders in patients with osteoporosis].
    Sánchez A, Libman J.
    Medicina (B Aires); 1995 Mar; 55(3):197-202. PubMed ID: 8544715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.